BioSpace News Archive

Business

AmTrust and Optum Workers’ Comp Partner to Reduce 13,000 Opioid Prescriptions in 6 Months

New Results Published in “AmTrust Opioid Prescription Risk Report”

May 21, 2019
·
2 min read
Deals

Xcenda Enhances Value Exchange between Payers and Manufacturers with Acquisition of Dymaxium

This acquisition will further simplify and streamline the necessary communication of clinical evidence and health economic information between manufacturers and population health decision makers.

May 21, 2019
·
4 min read
Business

Instead of More-of-the-Same Medicare For All, Something Much Better is Out There

Deane Waldman, M.D., MBA, author of Curing the Cancer in U.S. Healthcare, says the future of healthcare belongs to the states, not the federal government

May 21, 2019
·
2 min read
BioCapital

Divurgent Named to Modern Healthcare’s Best Places to Work for Seventh Year

For a seventh year, Modern Healthcare Magazine has named Divurgent, a healthcare IT consulting company, as one of the Best Places to Work in Healthcare for 2019.

May 21, 2019
·
3 min read
Drug Development

Oramed Completes Patient Recruitment of Phase IIb HbA1c Trial for Oral Insulin Capsule ORMD-0801

ORMD-0801 reaches significant milestone on path to potentially be the first commercial oral insulin capsule for the treatment of Type 2 diabetes

May 21, 2019
·
4 min read
BioMidwest

GEMCO Medical Awarded Prestigious VAWD® Accreditation by the National Association of Boards of Pharmacy

Accreditation Program Assures Best Practices and Security for Safe Drug and Device Distribution

May 21, 2019
·
2 min read
Business

New Brain Health & Research Institute To Fight And Reverse Brain Disease

Brain-Health Expert Dr. Mary Kay Ross, in Partnership with Institute for Systems Biology, Blends Scientific Advances with Clinical Medicine to Provide Patients with Hope and Proven Results

May 21, 2019
·
3 min read
Pharm Country

National Kidney Foundation to Develop First-Ever Patient Registry for Chronic Kidney Disease

New online platform will provide unique and powerful infrastructure for patient engagement, research studies and public health advocacy initiatives

May 21, 2019
·
4 min read
Biotech Beach

ALPHAEON Corporation to Pay Off $88 million of Outstanding Third-Party Debt

ALPHAEON intends to use the net proceeds from this offering to pay off a majority of its $88 million in third-party debt obligations, which are due in June 2019.

May 21, 2019
·
2 min read
Merck KGAA and GlucoMe Exploring Expansion for Digital Diabetes System

Digital diabetes solution provider, GlucoMe, announced that it is exploring expansion of its partnership with Merck KGaA, Darmstadt, Germany.

May 21, 2019
·
4 min read